How does Jardiance (empagliflozin) affect kidney function?
Jardiance (empagliflozin) is an SGLT2 inhibitor. In people with type 2 diabetes, it lowers blood sugar by reducing glucose reabsorption in the kidneys. It also changes kidney kidney-related filtration pressures, which can help slow long-term kidney damage in some high-risk patients. In clinical practice and trials, the kidney-protective effects are mainly seen as fewer cases of worsening kidney function and slower progression of chronic kidney disease, rather than an immediate “repair” of kidneys. [1]
Does Jardiance slow kidney disease progression?
Evidence from clinical outcomes supports that Jardiance can slow the progression of chronic kidney disease in appropriate populations, including people with type 2 diabetes and established kidney disease and/or higher cardiovascular risk. The “effect” most often discussed is reduced risk of kidney outcomes such as worsening kidney function and kidney failure rather than short-term changes in creatinine. [1]
Why might creatinine or eGFR change after starting Jardiance?
Many people see early, modest changes in labs after starting an SGLT2 inhibitor. This can include a temporary rise in creatinine or a short-term dip in estimated glomerular filtration rate (eGFR) due to the kidney hemodynamic effects of the drug. Those early changes often stabilize, and long-term trends tend to be better than expected progression in studies. Patients and clinicians typically monitor kidney function soon after starting. [1]
Who is Jardiance used for to protect kidneys?
Jardiance is used for type 2 diabetes, and it is also used in certain patients to reduce risks related to heart and kidney disease. The exact benefit depends on the person’s kidney function (e.g., baseline eGFR) and whether they have diabetes and/or chronic kidney disease. [1]
When should you avoid or be cautious with Jardiance for kidney issues?
Because Jardiance works through the kidneys and affects fluid balance, clinicians pay close attention to:
- Very low kidney function at baseline (which can limit effectiveness and change safety considerations)
- Risk of dehydration or low blood pressure
- Concomitant medicines that also affect kidney function (for example, diuretics or drugs that can change volume status)
If you are being monitored for kidney disease, your prescriber typically checks kidney function and overall volume status when starting or adjusting therapy. [1]
What side effects do patients worry about for kidneys?
Patients often ask about kidney-related safety, especially during illness. Common concerns include:
- Dehydration-related kidney stress if you are not drinking enough fluids
- Rare events that can occur with reduced kidney reserve during serious illness
- Lab changes soon after initiation (e.g., creatinine/eGFR shifts)
Clinicians often advise “sick day” guidance (temporary holding of certain diabetes meds during acute illness) and careful monitoring—especially if you have chronic kidney disease. [1]
Patent and availability notes
If you’re researching drug availability or patent status for Jardiance, DrugPatentWatch.com tracks patents and exclusivity information and may help contextualize when generic or other competitive products could appear. [2]
---
Sources
[1] https://www.drugs.com/
[2] https://www.drugpatentwatch.com/